Aliri Celebrates 30 Years of Bioanalytical Excellence and Scientific Innovation during AAPS
Download Scientific Posters from AAPS
We were proud to present 11 scientific posters at the recent AAPS PharmSci 360 convention, featuring a range of advanced analytical best practices leveraging validated biomarkers, MALDI mass spectrometry imaging, spatial omics, and more.
LBA vs LC-MS: competing technologies at a development crossroad
Join bioanalytical experts Shane Karnik, MS, and Matt Hartle, PhD for an on-demand webinar to learn more about the changing market landscape, considerations for each technology, and when it makes sense to consider LC-MS over LBA for your next large molecule program.
Meet the Aliri team this Fall:
-
Oxford Science Park Company Showcase | Oxford, UK | 4-8 Nov
-
SITC | Houston, TX | Nov 6 - 10
-
Babraham Company SHowcase | Cambridge, MA | 7 Nov
-
EBF | Barcelona, Spain | 20 - 22 Nov
Schedule a meeting with our experts
Advancing your molecule with speed and agility
Take your program from discovery to clinic.
Our specialized team of industry experts and seasoned scientists provides support for your project from discovery through clinical development and NDA approval.
Building a successful bioanalysis strategy
When choosing the right CRO for your drug development journey, it’s essential to consider a partner who’s committed to bringing life-saving therapies to market with speed and regulatory compliance.
Our scientists at Aliri Bioanalysis help make drug products that result in better outcomes for patients.
Every day, our team at Aliri Bioanalysis focuses on getting high-quality data for our clients on drugs in development. As a CRO, our dynamic work demands innovative MS technology for solving the latest challenging problem. In each stage of the process, we dare to rewrite the rules of standard practice as we help make real products that affect the lives of others.
Aliri Bioanalysis was formed when industry pioneers Pyxant Labs, ImaBiotech, and Tandem Labs joined forces to advance the bioanalytical CRO market.
Our mission is to support our customers with bringing life-saving therapies to market with speed and agility. We are focused on providing pharma and biotech companies with bioanalysis lab, spatial bioanalysis, and spatial biology solutions that will bring unique, comprehensive data to enable strategic decision making for lead optimization and strengthen regulatory submissions.
Building a successful bioanalysis strategy
When choosing the right CRO for your drug development journey, it’s essential to consider a partner who’s committed to bringing life-saving therapies to market with speed and regulatory compliance.
We provide a range of bioanalysis lab, spatial bioanalysis, and spatial biology solutions that will help you advance your molecule from discovery through clinical development and NDA approval, while being backed by a network of technical experts and seasoned scientists.
Aliri has the proven operational excellence across a range of traditional and cutting-edge technologies paired with the experience to support the unique needs of your development program.
Learn how you can utilize our team of dedicated scientists, program managers, quality specialists and industry experts.
Access quality data for filing your IND, NDA, or CTA with speed
Anticipate technical issues or potential roadblocks that may cause delays
Elucidate drug efficacy in the pertinent spatial context up to a cellular level, for more efficient and effective drug candidate evaluation and selection
Maximize the value of your drug discovery and development investments